Boc-L-His(Tos)-OH

Boc-L-His(Tos)-OH is a Boc-protected L-histidine building block bearing a Tosyl (Tos) protection on the imidazole side chain, designed to control histidine reactivity during peptide assembly. This protected amino acid derivative is widely used in peptide synthesis workflows where the Boc group provides N-terminal protection while the tosylated imidazole suppresses undesired side reactions and helps maintain sequence fidelity. Its protected functionality makes it a practical intermediate for preparing histidine-containing peptides and peptide segments under standard peptide coupling and deprotection conditions.

1. Solid-Phase Peptide Synthesis

Boc-L-His(Tos)-OH is commonly selected for solid-phase peptide synthesis of histidine-containing sequences where side-chain protection is required to prevent imidazole participation in coupling side reactions or premature deprotection. Peptide synthesis groups use this derivative to build peptides for structure-activity relationship studies, epitope mapping, and sequence optimization, particularly when histidine residues are positioned in regions that would otherwise be sensitive to harsh conditions. The Boc/Tos protection pattern supports reliable stepwise chain elongation and downstream processing to access the histidine side chain after peptide assembly.

2. Modified Histidine Peptides

Boc-L-His(Tos)-OH is used as a controlled histidine precursor for preparing peptides that require later side-chain functionalization or selective post-assembly processing. Researchers in chemical biology and protein engineering workflows often incorporate histidine residues as reactive or coordination-capable sites within peptide constructs, then perform subsequent derivatization steps after the peptide backbone is assembled. The tosyl-protected imidazole helps maintain the integrity of the histidine position during synthesis, enabling consistent handling for later conjugation, metal-binding studies, or generation of histidine-bearing peptide analogs for binding and interaction experiments.

3. Pharmaceutical Intermediate Development

Boc-L-His(Tos)-OH also serves as a practical protected amino acid intermediate for developing histidine-containing peptide-like intermediates used in medicinal chemistry programs. Process development teams and custom synthesis providers rely on this derivative to prepare well-defined, protected histidine building blocks that can be incorporated into larger fragments through peptide coupling strategies. The orthogonal protection approach (Boc on the amino group and Tos on the imidazole) supports reproducible intermediate handling and helps reduce variability when producing histidine-containing scaffolds for SAR campaigns and lead optimization chemistry.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. The spatiotemporal control of signalling and trafficking of the GLP-1R

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma